Redose
GLP-1 receptor agonists are now one of the most discussed tools for managing weight during the menopause transition, and for good reason: hormonal changes can make weight gain feel almost automatic, and GLP-1 medications address several of the underlying mechanisms. Redose is a free dose tracking app built to help you stay consistent, organized, and informed while you work through a GLP-1 protocol with your provider. Alongside dose logging, Redose also tracks calories, food, macros, and water in the same app, so you do not need a separate calorie counter running beside your injection tracker.
What GLP-1 Use During Menopause Actually Involves
Perimenopause and menopause bring falling estrogen levels, a shift in fat storage toward the abdomen, changes in insulin sensitivity, and often a genuine increase in appetite. These are physiological shifts, not failures of willpower, and they can make protocols that once worked less effective.
GLP-1 receptor agonists (semaglutide, tirzepatide, and related compounds) work by slowing gastric emptying, reducing appetite signaling in the brain, and improving glucose regulation. They are FDA-approved for chronic weight management in adults with obesity or with weight-related conditions, and large trials have included substantial numbers of perimenopausal and postmenopausal women with meaningful results. They are not approved as a menopause treatment, but physicians prescribe them to address the weight and metabolic changes that accompany the transition.
What this means practically: you may be on a weekly injection schedule for months or years, titrating through several dose steps, managing side effects at each new level, and adjusting based on how your body responds. That is a lot to keep track of, and an unstructured approach makes it easy to miss a dose, repeat an injection site, or lose track of which symptoms appeared at which dose level.
How Redose Helps at Every Stage
Redose was built for exactly this kind of long-running injectable protocol. Here is what it does for a GLP-1 user going through menopause:
- One-tap weekly logging. Set your protocol once (medication, starting dose, titration schedule) and Redose auto-fills the details each dose day. Tap to confirm, done in seconds.
- Injection-site body map. Every dose is mapped to a specific region on an anatomical body chart. Redose shows where you logged last time so rotation is automatic, not something you have to remember.
- Titration step tracking. As you step from, say, 0.25 mg to 0.5 mg to 1.0 mg semaglutide (typical reported schedule, set by your provider), your protocol timeline reflects exactly where you are in the ramp.
- Symptom and side-effect journal. Log nausea, fatigue, mood, appetite, and sleep quality right after each dose. Over time the app charts whether side effects are dose-related or improving with titration. This is the kind of structured data your prescriber needs to make adjustments confidently.
- Weight and metric sync. Redose syncs with Apple Health (iPhone) and Health Connect (Android) so your weight trend, steps, and other health data sit in the same timeline as your dose log. See whether weight trajectory is correlating with adherence.
- Live inventory and reorder reminders. Track how many pens or vials you have on hand. Redose alerts you when you are running low so you never reach dose day without medication.
- Reconstitution and dose calculators. If your provider prescribes compounded semaglutide in a vial, the free calculators help you work out the correct draw volume for your prescribed dose with no math required.
- Doctor-ready PDF export. Generate a clean adherence and symptom report to bring to any appointment, saving the ten minutes of "what dose are you on and how have you been feeling?"
All data is stored privately on your device first, with optional encrypted sync across your iPhone and Android devices. Nothing is sold to advertisers.
Track your food and water too
GLP-1 medications suppress appetite significantly, which is useful for weight loss but creates a real risk: eating too little protein or drinking too little water. On a reduced-calorie intake, hitting adequate protein and staying hydrated take deliberate effort, not just intuition. Redose lets you log meals, calories, and macros alongside your injection schedule so you can see at a glance whether your food intake is supporting the results you want. You can also log daily water intake with the built-in water tracker, which pairs naturally with the calorie tracker to give you a complete picture of nutrition and hydration in one place, no separate app needed. All of these trends appear on the same timeline as your doses and symptoms, so patterns are easy to spot and share with your provider.
Why Consistency Matters More Than People Expect
The clinical results for GLP-1 medications depend heavily on adherence. Missing doses disrupts the steady-state plasma levels these drugs rely on, and skipping a titration check-in means your provider cannot catch a side-effect pattern early. For women managing menopause alongside a demanding schedule (work, family, appointments), the friction of remembering and recording falls away when the app handles it.
Logging consistently also builds a picture over time. Weight loss during a GLP-1 protocol can be non-linear, and symptoms that feel alarming in week two may resolve completely by week eight. A journal you actually keep tells a far more useful story than memory alone.
If you are using or considering semaglutide, tirzepatide, or a related peptide alongside your menopause care, you can explore the Wegovy tracker and tirzepatide tracker pages for protocol-specific guidance, or download Redose free and set up your first protocol in under two minutes.
Redose is a tracking tool, not medical advice.